Israeli software SME delivering blockchain platforms and digital knowledge systems for manufacturing and pharmaceutical supply chains.
EKON is an Israeli software SME that builds digital platforms and blockchain-based systems for data-intensive industrial and healthcare applications. In WeldGalaxy, they contributed to a cloud-hosted B2B knowledge platform for the welding industry, incorporating blockchain, APIs, and knowledge-based engineering. In PharmaLedger, they shifted domain to pharmaceutical supply chains, working on blockchain frameworks to combat counterfeit medicines and enable machine-learning-driven health data marketplaces. Their core value to any consortium is applied software architecture — turning complex domain knowledge into usable digital infrastructure.
Blockchain appears in both WeldGalaxy (industrial B2B platform) and PharmaLedger (pharmaceutical supply chain integrity), making it the single consistent technical thread across their H2020 portfolio.
WeldGalaxy involved building a cloud-based knowledge platform with API integration and life cycle assessment (LCA) tools specifically for the welding manufacturing sector.
PharmaLedger engaged EKON in a blockchain-based framework targeting counterfeit medicine detection and clinical trial data management.
PharmaLedger included machine-learning health data marketplace components, suggesting EKON has contributed to health data exchange system design.
WeldGalaxy applied knowledge-based engineering, LCA, and consumables tracking to manufacturing workflows in the welding industry.
EKON entered H2020 in 2018 through WeldGalaxy with a focus on industrial digitalization — building cloud platforms, B2B knowledge bases, and blockchain tools for the welding and manufacturing sector. By 2020, their second project PharmaLedger marked a clear domain pivot toward healthcare and pharmaceutical supply chains, with blockchain remaining the unifying technology but now applied to counterfeit medicine tracking, clinical trials, and ML-driven health data markets. The trajectory suggests EKON is using blockchain as a portable capability they bring into whichever sector offers the next project, rather than deepening in a single vertical.
EKON is moving from industrial platform work toward healthcare data infrastructure, with blockchain as the consistent technical anchor — making them an interesting candidate for future health-data, traceability, or supply-chain integrity projects.
EKON has always participated as a consortium member, never as a coordinator, indicating they prefer to contribute specialized software capabilities within larger teams rather than drive project management. Both their projects were large-scale EU consortia — 36 unique partners across 16 countries from just two projects is well above average, suggesting they are comfortable operating in complex, multi-partner environments. For a potential partner, this means EKON is likely a reliable specialist contributor rather than a consortium builder.
Despite only two projects, EKON has engaged with 36 distinct consortium partners spanning 16 countries, reflecting participation in broad, geographically diverse EU research consortia. As an Israeli SME operating under Horizon 2020 association rules, their network extends well beyond their home region into core EU member states.
EKON is one of the few Israeli software SMEs in the H2020 portfolio with cross-domain blockchain experience in both manufacturing and pharmaceutical contexts — a pairing that most blockchain specialists lack. Their combination of knowledge-based engineering and applied ML for health data markets gives them a differentiated profile versus pure-play blockchain consultancies. For a consortium needing a software partner that can bridge industrial IoT/digital platforms with healthcare data compliance requirements, EKON has direct precedent in both areas.
